CMS advises Rantum Capital's medtech group on further acquisitions and strategic group development
Please confirm you are human to start the audio.
Frankfurt/M. – The medtech group established by Rantum Capital and specialising in precision surgical instruments is continuing its growth strategy with further acquisitions and new growth financing.
Following the acquisition of Tontarra Medizintechnik GmbH in April 2026, the group has strengthened its market position and strategically expanded its product and customer portfolio by acquiring S. u. A. Martin GmbH & Co. and Getsch+Hiller Medizintechnik GmbH.
A CMS team led by Dr Hendrik Hirsch provided comprehensive legal advice to the medtech group on the corporate acquisitions and the group's strategic development. The complex regulatory advice was provided under the leadership of Dr Imme Kley and Dr Roland Wiring. The further advice covered in particular corporate law and transaction-related issues as well as other legal aspects relating to employment law, intellectual property and technology, property law, tax law, finance and competition law.
By acquiring Tontarra in April 2026, Rantum Capital had laid the foundations for the development of the medtech group. These further acquisitions complement the existing business with strategically important and high-growth product segments. At the same time, the integration of these companies is intended to unlock additional operational synergies and further strengthen the group's international competitive position.
The Group specialises in developing and manufacturing high-quality precision surgical instruments and employs just under 300 staff across four sites.
